Therapy of hepatocellular carcinoma with iodine-131-lipiodol: Results in a large German cohort

NuklearMedizin

Volumn 45, Issue 4, 2006, Pages 185-192

  Risse, Jörn H ^a,c   Rabe, C ^a   Pauleit, D ^a,b   Reichmann, K ^a   Menzel, C ^b   Grunwald F ^b   Strunk, H ^a   Biersack, H J ^a   Palmedo, H ^a  

^a UNIVERSITY OF BONN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c Radiology and Nuclear Medicine Institute   (Germany)

Author keywords

Cancer therapy; Hepatocellular carcinoma; Iodine 131 lipiodol; Long term analysis; Portal vein thrombosis

Indexed keywords

IODINATED POPPYSEED OIL; IODINE 131;

ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; LIVER CELL CARCINOMA; SIDE EFFECT; TUMOR VOLUME;

EID: 33748528570     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1625116     Document Type: Article

References (30)

1. Becker N, Warendorf J. Krebsatlas der Bundesrepublik Deutschland 1981-1990. 3. Aufl. Berlin: Springer 1998.
2. Bhattacharya S, Novell JR, Dusheiko GM et al. Epirubicin-Lipiodol chemotherapy versus 131 iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma. Cancer 1995; 76: 2202-10.
3. Bhattacharya S, Dhillon AP, Winslet MC et al. Human liver cancer cells and endo-thelial cells incorporate iodised oil. Br J Cancer 1996; 73: 877-81.
4. Bruix J, Llovet JM, Castells A et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998; 27: 1578-83.
5. Cheng JC, Wud JK, Huanga CM et al. Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description. Radiother Oncol 2002; 63: 41-5.
6. Chung J, Park J, Han J et al. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 1996; 198: 33-40.
7. De Baere T, Dufaux J, Roche A et al. Circulatory alterations induced by intra-arterial injection of iodized oil and emulsions of iodized oil and doxorubicin: experimental study. Radiology 1995; 194: 165-70.
8. De Baere T, Taourel P, Tubiana JM et al. Hepatic intraarterial 1311 iodized oil for treatment of hepatocellular carcinoma in patients with impeded portal venous flow. Radiology 1999; 212: 665-8.
9. Garin E, Laffont S, Rolland Y et al. Safe radiation exposure of medical personnel by using simple methods of radioprotection while administering 131I-Lipiodol therapy for hepatocellular carcinoma. Nucl Med Commun 2003; 24: 671-8.
10. Gattoni F, Cornalba G, Brambilla G et al. Survival of 184 patients whith hepatocellular carcinoma in cirrhotic liver treated with chemoembolization. A multicenter study. Radiol Med (Torino) 1998; 95: 362-8.
11. Hatanaka Y, Yamashita Y, Takahashi M et al. Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management. Radiology 1995; 195: 747-52.
12. Hillert C, Rogiers X. Die kurative Therapie des hepatozellulären Karzinoms (HCC). Resektion oder Transplantation? Internist 2000; 41: 191-7.
13. Ho S, Lau WY, Leung TW et al. Internal radiation therapy for patients with primary or metastatic hepatic cancer: a review. Cancer 1998; 83: 1894-907.
14. Kobayashi H, Hidaka H, Kajiya Y et al. Treatment of hepatocellular carcinoma by transarterial injection of anticancer agents in iodized oil suspension or of radioactive iodized oil solution. Acta Radiol 1986; 27: 139-47.
15. Lambert B, van de Wiele C. Treatment of hepatocellular carcinoma by means of radiopharmaceuticals. Review. Eur J Nucl Med Mol Imaging 2005; 32: 980-9.
16. Lau WY, Leung TW, Ho SK et al. Adjuvant intraarterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet 1999; 353: 797-801.
17. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003;37:429-42.
18. Llovet JM, Fuster J, Bruix J, Barcelona-Clinic Liver Cancer Group. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transplant 2004; 10: S115-20.
19. Monto A, Wright TL. The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol 2001; 28: 441-9.
20. Okuda K, Ohtsuki T, Obata H et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 1985; 56: 918-28.
21. Parkin MD, Bray F, Ferlay J et al. Estimating the world cancer burden: globocan 2000. Int J Cancer 2001; 94: 153-6.
22. Pelletier G, Ducreux M, Gay F et al. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Group CHC. J Hepatol 1998; 29: 129-34.
23. Preketes A, Boyd S, Cooper D et al. Pulmonary toxicity following Lipiodol 1-131 treatment for liver tumours. Reg Cancer Treatment 1996; 9: 21-6.
24. Rabe C, Pilz T, Klostermann C et al. Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol 2001; 7: 208-15.
25. Raoul JL, Guyader D, Bretagne JF et al. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med 1994; 35: 1782-7.
26. 131I-labeled- iodized oil in the treatment of hepatocellular carcinoma. Hepatology 1997; 26: 1156-61.
27. Risse JH, Ponath C, Palmedo H et al. Radiation exposure and radiation protection of the physician in I-131-Lipiodol therapy of liver tumours. Eur J Nucl Med 2001; 28: 914-8.
28. Schwartz JD, Beutler AS. Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials - II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma. Anticancer Drugs 2004; 15: 439-52.
29. Yamamoto J, Okada S, Shimada K et al. Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001; 34: 707-13.
30. Yoo HS, Lee JT, Kim KW et al. Nodular hepatocellular carcinoma. Treatment with subsegmental intraarterial injection of iodine-131-labeled oil. Cancer 1991; 68: 1878-84.